Meet the team

Neill Mackenzie, PhD
CEO, Trimunocor Ltd.
CBO, Biotecnol Ltd.
CEO, Roji Ltd.

Dr. Neill Mackenzie is an internationally networked pharmaceutical executive and a serial entrepreneur with extensive operational, commercial, licensing and R&D background in academia, pharma and biotech companies. After completing his PhD in immunology and postdoctoral work at the National Institute for Medical Research with the MRC, he became the Wellcome Trust lecturer in immunology in the University of London. He joined Wellcome plc as Head of the Immunology and Anti-Infectives Department continuing with Mallinckrodt Inc. after it acquired the division.

Over the last 16 years, Dr. Mackenzie has served on the boards of Trimunocor Ltd. as founder and CEO, Biotecnol Ltd. as CBO, Cellular therapeutics Ltd., CMP Therapeutics Ltd. as CEO, Roji Ltd. as Founder and CEO, Medigene AG (listed on the German Börse) as Senior Vice President, Business Development and Commercial Strategy, Avidex Ltd. as CBO, Oxford BioMedica plc (listed on the LSE), and BioMedica Inc. as Co-founder and EVP of Business Development and Corporate Strategy, and with Cambridge Genetics Ltd. as Co-founder and CEO. In these companies he took primary responsibility for all elements of corporate business development, including mergers and acquisitions, partnering, licensing, public relations and investor relations. As an executive director with profit and loss responsibilities, in listed (both the full London Stock Exchange (LSE) and the Alternative Investment Market) and private companies, he has raised over $150 million equity capital from private and public funds, and he has completed numerous deals with pharmaceutical companies globally.